A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.
I. R. MacPherson
No relevant relationships to disclose
D. Bissett
No relevant relationships to disclose
R. D. Petty
No relevant relationships to disclose
B. Tait
No relevant relationships to disclose
L. M. Samuel
No relevant relationships to disclose
J. MacDonald
No relevant relationships to disclose
M. Smith
No relevant relationships to disclose
J. A. Birse-Archbold
Employment or Leadership Position - CXR Biosciences
Stock Ownership - CXR Biosciences
A. L. Barnett
Employment or Leadership Position - CXR Biosciences
Stock Ownership - CXR Biosciences
C. R. Wolf
Employment or Leadership Position - CXR Biosciences
Stock Ownership - CXR Biosciences
C. R. Elcombe
Employment or Leadership Position - CXR Biosciences
Stock Ownership - CXR Biosciences
A. Jeynes-Ellis
Consultant or Advisory Role - CXR Biosciences
T. R. J. Evans
Research Funding - CXR Biosciences